Novartis Lifts FullYear Sales and Profit Forecasts Amid Strong Operational Momentum Market Rally Drives Portfolio Gains Top and Bottom Performers Highlighted Analysts Eye ResMeds Sleep Tech Dominance What the Ratings Suggest US Governments 2 Billion Quantum Computing Incentives Boost Sector Sentiment UK Exports to US Slump 25 Following Trumps Tariff Blitz Trade Deficit Emerges Wall Street Divided on Paramount Skydance Outlook Amid Industry Uncertainty Healthcare and Tech Lead as Broad Market Edges Higher